Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B

Journal of Viral Hepatitis

Volumn 18, Issue 3, 2011, Pages 216-226

  John Von Freyend, M ^a   Untergasser, A ^a   Arzberger, S ^b   Oberwinkler, H ^c   Drebber, U ^d   Schirmacher, P ^c   Protzer, U ^b,e  

^a UNIVERSITY OF COLOGNE   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Ad HBV; adenoviral vector; HBV; hepatitis B; liver disease

Indexed keywords

ADENOVIRUS VECTOR; ALANINE AMINOTRANSFERASE; GAMMA INTERFERON;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; GENOME; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMORAL IMMUNITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

ANIMALS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENOME, VIRAL; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; IMMUNOPHENOTYPING; MALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TRANSFECTION; VIRUS REPLICATION;

EID: 79951490994     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01302.x     Document Type: Article

References (36)

1. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73. (Pubitemid 43042691)
2. Ganem D, Prince AM,. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350: 1118-1129. (Pubitemid 38298992)
3. Summers J, Mason WS,. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982; 29: 403-415. (Pubitemid 12024833)
4. Ganem D, Schneider R,. Hepadnaviridae: the Viruses and Their Replication. In:, Knipe DM, Howley PM, eds. Fields Virology. Volume 2. 5th edn. Philadelphia: Lippincott Williams & Wilkins, 2007: 2923-2970.
5. Thimme R, Wieland S, Steiger C, et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003; 77: 68-76. (Pubitemid 36004947)
6. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV,. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284: 825-829. (Pubitemid 29291352)
7. Korba BE, Cote PJ, Wells FV, et al. Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues. J Virol 1989; 63: 1360-1370. (Pubitemid 19061378)
8. Jilbert AR, Wu TT, England JM, et al. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol 1992; 66: 1377-1388.
9. Untergasser A, Zedler U, Langenkamp A, et al. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 2006; 43: 539-547.
10. Kock J, Theilmann L, Galle P, Schlicht HJ,. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology 1996; 23: 405-413. (Pubitemid 26087152)
11. Michalak TI, Pardoe IU, Coffin CS, et al. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 1999; 29: 928-938. (Pubitemid 29109612)
12. Yang PL, Althage A, Chung J, Chisari FV,. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A 2002; 99: 13825-13830. (Pubitemid 35215465)
13. Sprinzl MF, Oberwinkler H, Schaller H, Protzer U,. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J Virol 2001; 75: 5108-5118. (Pubitemid 32448533)
14. Guidotti LG, Matzke B, Schaller H, Chisari FV,. High-level hepatitis B virus replication in transgenic mice. J Virol 1995; 69: 6158-6169.
15. Guidotti LG, Chisari FV,. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19: 65-91. (Pubitemid 32368030)
16. Feitelson MA, DeTolla LJ, Zhou XD,. A chronic carrierlike state is established in nude mice injected with cloned hepatitis B virus DNA. J Virol 1988; 62: 1408-1415. (Pubitemid 18082956)
17. Takahashi H, Fujimoto J, Hanada S, Isselbacher KJ,. Acute hepatitis in rats expressing human hepatitis B virus transgenes. Proc Natl Acad Sci U S A 1995; 92: 1470-1474.
18. Huang LR, Wu HL, Chen PJ, Chen DS,. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A 2006; 103: 17862-17867.
19. Bramson JL, Graham FL, Gauldie J,. The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr Opin Biotechnol 1995; 6: 590-595.
20. Sprinzl M, Dumortier J, Protzer U,. Construction of recombinant adenoviruses that produce infectious hepatitis B virus. Methods Mol Med 2004; 96: 209-218.
21. Sprengers D, van derMolenRG, Kusters JG, et al. Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans. J Hepatol 2006; 45: 182-189.
22. Zhang Z, Protzer U, Hu Z, Jacob J, Liang TJ,. Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner. J Virol 2004; 78: 4566-4572. (Pubitemid 38501077)
23. Weber O, Schlemmer KH, Hartmann E, et al. Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model. Antiviral Res 2002; 54: 69-78. (Pubitemid 34327685)
24. Untergasser A, Protzer U,. Hepatitis B virus-based vectors allow the elimination of viral gene expression and the insertion of foreign promoters. Hum Gene Ther 2004; 15: 203-210. (Pubitemid 38210534)
25. Dumortier J, Schonig K, Oberwinkler H, et al. Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice. Gene Ther 2005; 12: 668-677. (Pubitemid 40561505)
26. Wieland SF, Eustaquio A, Whitten-Bauer C, Boyd B, Chisari FV,. Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc Natl Acad Sci U S A 2005; 102: 9913-9917. (Pubitemid 40993667)
27. Quasdorff M, Hosel M, Odenthal M, et al. A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation. Cell Microbiol 2008; 10: 1478-1490. (Pubitemid 351837268)
28. Isogawa M, Kakimi K, Kamamoto H, Protzer U, Chisari FV,. Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen. Virology 2005; 333: 293-300. (Pubitemid 40250113)
29. Honigwachs J, Faktor O, Dikstein R, Shaul Y, Laub O,. Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer. J Virol 1989; 63: 919-924. (Pubitemid 19057261)
30. Ren S, Nassal M,. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors. J Virol 2001; 75: 1104-1116. (Pubitemid 32094669)
31. Maini MK, Boni C, Lee CK, et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000; 191: 1269-1280. (Pubitemid 30227116)
32. Jogler C, Hoffmann D, Theegarten D, Grunwald T, Uberla K, Wildner O,. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species. J Virol 2006; 80: 3549-3558.
33. Cavanaugh VJ, Guidotti LG, Chisari FV,. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol 1998; 72: 2630-2637. (Pubitemid 28175496)
34. Hodgson PD, Michalak TI,. Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection. Hepatology 2001; 34: 1049-1059. (Pubitemid 33032042)
35. Nakamura I, Nupp JT, Cowlen M, et al. Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis factor-alpha messenger RNAs. Hepatology 2001; 33: 439-447. (Pubitemid 32119034)
36. Murray JM, Wieland SF, Purcell RH, Chisari FV,. Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci U S A 2005; 102: 17780-17785. (Pubitemid 41803574)